Today, science writer Carl Zimmer explains the decision-making process, how long the suspension might last and the impact it could have not only in the U.S. but around the world.
Guest: Carl Zimmer, a science writer and author of the “Matter” column for The New York Times.
Today
Want to Enjoy Music More? Go For a Run.
Ben Ratliff, a music critic and avid runner, always ran in silence. Then he discovered how music opened up to him — while running. It changed his entire approach to criticism and listening. He calls it “running the song.”Today, for the New York City Marathon, Ben talks with our h ... Show More
36m 12s
Yesterday
Martin McDonagh Has a Vision for Hope. It's Not for the Faint of Heart.
The writer-director, known for his dark and bleak work, believes in film’s power to change our lives.Thoughts? Email us at theinterview@nytimes.comWatch our show on YouTube: youtube.com/@TheInterviewPodcastFor transcripts and more, visit: nytimes.com/theinterview For more informa ... Show More
49m 59s
Oct 30
The Art of the Pardon: How Trump Turned Clemency Into a Business
In the final stretch of the midterm election campaign, polls have found that voters are latching onto the perceived corruption of the Trump administration.Kenneth P. Vogel, a New York Times investigative journalist, explores one major story line feeding that perception: how those ... Show More
33m 36s
Apr 2021
Coronavirus: How Scary Are the Variants?
UPDATE 4/13/21: Since this episode published, there has been some evidence linking the Johnson & Johnson coronavirus vaccine to rare blood clots. As of April 13, there were six cases in the U.S. out of more than 6.8 million doses, and one person had died. The CDC and FDA have rec ... Show More
33m 54s